日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study

可能影响美国跨性别女性获得和使用长效注射卡博特韦的医疗服务提供者因素:一项定性研究的结果

Rael, Christine Tagliaferri; Das, Doyel; Porter, Jonathan; Lopez-Ríos, Javier; Abascal, Elena; Dolezal, Curtis; Vaughn, Michael P; Giffenig, Pilar; Lopez, Jasmine M; Stonbraker, Samantha; Sun, Christina; Velasco, Roque Anthony; Bitterfeld, Leandra; Bockting, Walter O; Bauermeister, Jose

Transgender Women's Experiences Using SMARTtest, a Smartphone Application to Facilitate Self- and Partner-HIV/Syphilis Testing Using the INSTI Multiplex

跨性别女性使用SMARTtest(一款利用INSTI多重检测技术进行自我及伴侣HIV/梅毒检测的智能手机应用程序)的体验

Rael, Christine Tagliaferri; Kutner, Bryan A; Lentz, Cody; Lopez-Ríos, Javier; Dolezal, Curtis; Arumugam, Siddartha; Sia, Samuel K; Balán, Iván C

Transgender Women's Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)

跨性别女性在接受长效注射卡博特韦(CAB-LA)进行 HIV 暴露前预防(PrEP)时,在选择定制注射给药策略方面面临的障碍、促进因素和偏好

Rael, Christine Tagliaferri; Lopez-Ríos, Javier; McKenna, Stacey A; Das, Doyel; Dolezal, Curtis; Abascal, Elena; Carballo-Diéguez, Alex; Schnall, Rebecca; Hope, Thomas J; Bauermeister, José; Bockting, Walter